Glenmark Pharmaceuticals Ltd 2025 Sustainability Report
Company: Glenmark Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Sustainability Report
Pages: 67
The report describes Glenmark's transition from an impact materiality assessment to double materiality, evaluating both impact and financial materiality. It reports SBTi-approved commitments to reduce absolute Scope 1 and 2 emissions by 35% by FY2035. The company says it achieved water neutrality and is now water positive, while its environmental sections also report 89% wastewater recycling and zero-waste-to-landfill progress.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.